Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Parexel unveiled its COVID-19 Risk Mitigation offering, which leverages the company’s experience with global viral outbreaks as well as cGMP inspection and CMC review processes to ensure that manufacturers can safely and confidently continue ...
read more
U.S. Pharmacopeia (USP) has launched a new program to support scientists, developers and manufacturers worldwide.
read more
Mylan announced a global collaboration with Gilead Sciences to expand access to the investigational antiviral remdesivir for the potential treatment of COVID-19.
read more
Fresenius Medical Care North America's Renal Therapies Group is preparing its first shipment of multiBic dialysate solutions for use in continuous renal replacement therapy.
read more
Review the latest news and information on the Coronavirus Pandemic.
read more
Yourway and Firma Clinical Research are joining to provide coordinated supply and product deliveries and administration services for virtual/decentralized clinical trials.
read more
Skyhawk Therapeutics has expanded its strategic collaboration with Merck to discover, develop, and commercialize small molecules that modulate RNA splicing.
read more
CiRA Foundation and the CGT Catapult are launching a new collaborative research project focused on induced pluripotent stem cell characterization.
read more
Neovii has signed a research and license agreement with Tel Aviv University to develop a novel COVID-19 vaccine.
read more
During COVID-19, FDA will continue to utilize and implement additional alternative inspection tools and approaches while postponing domestic and foreign routine surveillance inspections.
read more
Mologic and BioSure are working together to produce a COVID-19 antibody self-test.
read more
Review the latest news and information on the Coronavirus Pandemic.
read more
Integra Pharma Solutions has formally withdrawn its EUA application in connection with its partner’s manufacture of the SARS-CoV-2 IgM/IgG Antibody Rapid Test Kit from consideration in response to FDA guidance.
read more
Group announced it is shipping Affimer reagents for COVID-19 antigen testing to its diagnostic test development partners.
read more
In response to scammers on the internet selling unproven medical products, the FDA has taken a number of steps to find and stop those selling unapproved products that fraudulently claim to mitigate, prevent, treat, diagnose or cure COVID-19.
read more